US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 44.240
  • +0.390+0.89%
Close Apr 26 16:00 ET
  • 43.310
  • -0.930-2.10%
Post 16:05 ET
3.64BMarket Cap-5362P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Ultragenyx Pharmaceutical Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 2, 2024

Revenue(YoY)

116.81M

+16.24%
EPS(YoY)

-1.75

+24.82%

Strong Buy

Apr 27, 2024

Ultragenyx Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 16 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 125.872M--
May 2, 20242024/Q1-- / 116.815M--
Feb 15, 20242023/Q4127.392M / 120.989M--
Nov 2, 20232023/Q398.052M / 102.875M--
Aug 3, 20232023/Q2108.309M / 104.987M--
May 4, 20232023/Q1100.496M / 103.902M--
Feb 16, 20232022/Q4103.348M / 105.114M--
Nov 2, 20222022/Q390.703M / 95.704M--
Jul 28, 20222022/Q289.343M / 87.332M--
May 5, 20222022/Q179.935M / 84.248M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 125.872M--
May 2, 20242024/Q1-- / 116.815M--
Feb 15, 20242023/Q4127.392M / 120.989M--
Nov 2, 20232023/Q398.052M / 102.875M--
Aug 3, 20232023/Q2108.309M / 104.987M--
May 4, 20232023/Q1100.496M / 103.902M--
Feb 16, 20232022/Q4103.348M / 105.114M--
Nov 2, 20222022/Q390.703M / 95.704M--
Jul 28, 20222022/Q289.343M / 87.332M--
May 5, 20222022/Q179.935M / 84.248M--

Unlock Free Earnings Estimates

Ultragenyx Pharmaceutical Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 27, 2024

Strong Buy

  • Buy

    94.44%
  • Hold

    5.56%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg